TARGETING EXTRACELLULAR NUCLEOSIDE METABOLISM AS A STRATEGY TO POTENTIATE THE EFFECTS OF IMMUNOTHERAPY IN PANCREATIC DUCTAL ADENOCARCINOMA
$602,814FY2024Defense Health AgencyDOD
Board Of Regents Of The University Of Nebraska
Board Of Regents Of The University Of Nebraska